Literature DB >> 11102429

In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.

A Schulte, P Heisig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102429     DOI: 10.1093/jac/46.6.1037

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  3 in total

1.  Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.

Authors:  Dilek Ince; Xiamei Zhang; L Christine Silver; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli.

Authors:  Sonia K Morgan-Linnell; Lynn Zechiedrich
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

3.  Two validated spectrofluorometric methods for determination of gemifloxacin mesylate in tablets and human plasma.

Authors:  Noha N Atia; Ashraf M Mahmoud; Salwa R El-Shabouri; Wesam M El-Koussi
Journal:  Int J Anal Chem       Date:  2013-05-16       Impact factor: 1.885

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.